AW Wallace, S Au… - Anesthesiology, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > Current ... Cited by 1 - Related articles - All 5 versions
[PDF] from sphinxsai.comDK Jain, P Patel, AS Khan… - Development, 2011 - sphinxsai.com International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol. 3, No.2, pp 766-771, April-June 2011 ... Development and Validation of a RP-HPLC method ... Deepak Kumar Jain1*, Pratibha Patel1, Abu Sahma Khan2 Related articles - View as HTML
J Smith, A Ferland, J Méthot, P Brassard… - Nutrition, Metabolism …, 2011 - Elsevier Atenolol is a beta-1 adrenergic antagonist commonly prescribed for the treatment of systemic hypertension or coronary artery disease yet its use in individuals with type 2 diabetes mellitus (T2DM) is controversial due to potentially negative side effects on insulin resistance. Non- ... Cited by 1 - Related articles - All 3 versions
[HTML] from nih.govD Gupta, S Srivastava, RK Dubey… - Indian Journal of …, 2011 - ncbi.nlm.nih.gov Severe cardiovascular responses in the form of tachycardia and hypertension following nasal speculum insertion occur during sublabial rhinoseptal trans-sphenoid approach for resection of small pituitary tumours. We compare the effects of preoperative administration of ... Related articles - All 4 versions
R Gupta, S Kirby, F Lawler… - The Journal of the …, 2011 - ncbi.nlm.nih.gov 1. J Okla State Med Assoc. 2011 Apr;104(4):130-1. Does atenolol reduce adverse cardiovascular outcomes in adult patients with hypertension? Gupta R, Kirby S, Lawler F, Welborn TL. Research Division, University of Oklahoma ...